1.
Afzal S. Neuroendocrine Tumors, Possible Targets for Tyrosine Kinase Inhibitor Therapy. Int J Pathol. 2020;17(4):156-161. Accessed March 22, 2026. https://www.jpathology.com/index.php/OJS/article/view/514